文献速递湿疹皮炎与荨麻疹

降压药物与老年人湿疹性皮炎的相关性

Antihypertensive Medications and Eczematous Dermatitis in Older Adults.
PubMed 文献 · JAMA Dermatol · 2024-01-01

IMPORTANCE: Rates of physician-diagnosed eczema have been increasing among older adults, but little is known regarding the pathophysiologic processes and best treatments in this subgroup.…

要点

  • 老年人使用任何降压药与湿疹性皮炎风险增加29%相关(HR 1.29,95%CI 1.26-1.31)。
  • 利尿剂(HR 1.21)和钙通道阻滞剂(HR 1.16)的风险效应量最大。
  • ACEI(HR 1.02)和β受体阻滞剂(HR 1.04)的风险效应量最小。

核心结论

  • 降压药物与老年人湿疹性皮炎发生率轻度增加相关,效应量因药物类别而异。

主要发现

  • 中位随访6年期间,湿疹性皮炎总体患病率为6.7%,降压药使用者发病率为12/1000人年,未使用者为9/1000人年。
  • 调整后Cox模型显示,使用任何降压药者发生任何湿疹性皮炎的HR为1.29(95%CI 1.26-1.31)。
  • 利尿剂HR 1.21(95%CI 1.19-1.24),钙通道阻滞剂HR 1.16(95%CI 1.14-1.18)。
  • ACEI HR 1.02(95%CI 1.00-1.04),β受体阻滞剂HR 1.04(95%CI 1.02-1.06)。

临床怎么用

  • 老年人出现湿疹性皮炎时,临床医生可考虑降压药物(尤其是利尿剂和钙通道阻滞剂)的可能贡献以指导管理。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Rates of physician-diagnosed eczema have been increasing among older adults, but little is known regarding the pathophysiologic processes and best treatments in this subgroup. Preliminary data suggest that medications-antihypertensive medications in particular-may contribute to eczematous dermatitis; however, there are limited population-based data on the proportion of eczematous dermatitis diagnoses among older adults that may be attributed to antihypertensive drugs. OBJECTIVES: To determine whether antihypertensive drug use is associated with eczematous dermatitis in older adults. DESIGN, SETTINGS, AND PARTICIPANTS: This was a longitudinal cohort study of a population-based sample of individuals 60 years and older without a diagnosis of eczematous dermatitis at baseline. It was conducted at primary care practices participating in The Health Improvement Network in the United Kingdom from January 1, 1994, to January 1, 2015. Data analyses were performed from January 6, 2020, to February 6, 2024. EXPOSURE: Exposure date by first prescription for an antihypertensive drug within each drug class. MAIN OUTCOME MEASURES: Newly active eczematous dermatitis was based on the first date for 1 of the 5 most common eczema codes used in a previously validated algorithm. RESULTS: Among the total study sample of 1 561 358 older adults (mean [SD] age, 67 [9] years; 54% female), the overall prevalence of eczematous dermatitis was 6.7% during a median (IQR) follow-up duration of 6 (3-11) years. Eczematous dermatitis incidence was higher among participants receiving antihypertensive drugs than those who did not (12 vs 9 of 1000 person-years of follow-up). Adjusted Cox proportional hazard models found that participants who received any antihypertensive drugs had a 29% increased hazard rate of any eczematous dermatitis (hazard ratio [HR], 1.29; 95% CI, 1.26-1.31). When assessing each antihypertensive drug class individually, the largest effect size was observed for diuretic drugs (HR, 1.21; 95% CI, 1.19-1.24) and calcium channel blockers (HR, 1.16; 95% CI, 1.14-1.18), and the smallest effect sizes were for angiotensin-converting enzyme inhibitors (HR, 1.02; 95% CI, 1.00-1.04) and β-blockers (HR, 1.04; 95% CI, 1.02-1.06). CONCLUSIONS AND RELEVANCE: This cohort study found that antihypertensive drugs were associated with a small increased rate of eczematous dermatitis, with effect sizes largest for calcium channel blockers and diuretic drugs, and smallest for angiotensin-converting enzyme inhibitors and β-blockers. Although additional research is needed to understand the mechanisms underlying the association, these data could be helpful to clinicians to guide management when a patient presents with eczematous dermatitis in older age.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Ye M, Chan LN, Douglas I, et al. Antihypertensive Medications and Eczematous Dermatitis in Older Adults. JAMA Dermatol. 2024. PMID: 38776099. doi:10.1001/jamadermatol.2024.1230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。